Potrero Capital Research’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CPUH.WS
RCM
JRCM
SCM
LP
PIF
AGC
SRCM
PAMP
AC
TP
Potrero Capital Research's CPUH.WS Position: Q4 2022 in Review
Potrero Capital Research sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q4 2022, closing a stake of 37,500 shares — an estimated $2K sold.
Potrero Capital Research first reported a position in CPUH.WS in Q1 2021 and held it in 6 quarters. The position peaked at $57K in Q2 2021. 70 funds tracked by Wall St. Rank hold CPUH.WS as of Q4 2022.
- Potrero Capital Research reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
- Potrero Capital Research sold 37,500 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q4 2022, an estimated $2K.
- Potrero Capital Research first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2021 and held it in 6 quarters.
- Potrero Capital Research's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $57K in Q2 2021.
- 70 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q4 2022.
Based on Potrero Capital Research's 13F filing for Q4 2022, filed 14 Feb 2023.